Summary of nonclinical data for gene therapy developmental candidate HMI-203 for mucopolysaccharidosis type II (MPS II, or Hunter syndrome)

Molecular Genetics and Metabolism
February 1, 2022
Cited by 0

Abstract


Related Papers

No related papers found

Powered by citation graph analysis